Avidity Biosciences, Inc.
Compositions and methods of treating muscle atrophy and myotonic dystrophy
Last updated:
Abstract:
Disclosed herein are polynucleic acid molecules, pharmaceutical compositions, and methods for treating muscle atrophy or myotonic dystrophy.
Status:
Grant
Type:
Utility
Filling date:
26 Feb 2021
Issue date:
15 Feb 2022